SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Nearly 16% of American adults—that's close to one in six—now has diabetes, according to the latest data from the U.S. Centers ...

Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Our list of online ... brand-name semaglutide medications. The primary difference is the dosing and FDA approval. Wegovy is ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss ... get ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...